Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 45 | $88,600,199 |
| Sells | 137 | $154,017,390 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 26 Mar 2025 19:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 24 Mar 2025 | Sale | 1,956 | 54.11 | 105,839 | I |
| 26 Mar 2025 19:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 24 Mar 2025 | Sale | 3,026 | 54.11 | 163,737 | I |
| 26 Mar 2025 19:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 24 Mar 2025 | Sale | 756 | 54.11 | 40,907 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 19 Mar 2025 | Sale | 13,517 | 54.02 | 730,188 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 19 Mar 2025 | Sale | 20,911 | 54.02 | 1,129,612 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 19 Mar 2025 | Sale | 5,228 | 54.02 | 282,417 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 20 Mar 2025 | Sale | 941 | 54.01 | 50,823 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 20 Mar 2025 | Sale | 1,457 | 54.01 | 78,693 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 20 Mar 2025 | Sale | 364 | 54.01 | 19,660 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 21 Mar 2025 | Sale | 3,412 | 54 | 184,248 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 21 Mar 2025 | Sale | 5,279 | 54 | 285,066 | I |
| 21 Mar 2025 20:00 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 21 Mar 2025 | Sale | 1,320 | 54 | 71,280 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 68,766 | 54.29 | 3,733,306 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 106,384 | 54.29 | 5,775,587 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 26,596 | 54.29 | 1,443,897 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 136 | 55.01 | 7,481 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 211 | 55.01 | 11,607 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 10 Mar 2025 | Sale | 53 | 55.01 | 2,916 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 11 Mar 2025 | Sale | 9,222 | 54.01 | 498,080 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 11 Mar 2025 | Sale | 14,267 | 54.01 | 770,561 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 11 Mar 2025 | Sale | 3,567 | 54.01 | 192,654 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 603 | 55.05 | 33,195 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 933 | 55.05 | 51,362 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 233 | 55.05 | 12,827 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 27,750 | 54.44 | 1,510,710 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 42,930 | 54.44 | 2,337,109 | I |
| 12 Mar 2025 21:34 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 12 Mar 2025 | Sale | 10,733 | 54.44 | 584,305 | I |
| 19 Feb 2025 17:52 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 14 Feb 2025 | Purchase | 17,962 | 9.9 | 177,824 | I |
| 19 Feb 2025 17:52 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 14 Feb 2025 | Purchase | 29,540 | 9.85 | 290,969 | I |
| 19 Feb 2025 17:52 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 18 Feb 2025 | Purchase | 49,070 | 10.84 | 531,919 | I |
| 19 Feb 2025 17:52 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 18 Feb 2025 | Purchase | 94,100 | 10.84 | 1,020,044 | I |
| 10 Feb 2025 16:28 | SION | Sionna Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 10 Feb 2025 | Purchase | 550,000 | 18 | 9,900,000 | I |
| 14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 10 Jan 2025 | Sale | 126,209 | 0.66 | 83,298 | I |
| 14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 13 Jan 2025 | Sale | 17,986 | 0.64 | 11,511 | I |
| 14 Jan 2025 17:17 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 14 Jan 2025 | Sale | 79,024 | 0.6 | 47,414 | I |
| 08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 06 Jan 2025 | Sale | 19,481 | 0.77 | 15,000 | I |
| 08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 07 Jan 2025 | Sale | 52,536 | 0.71 | 37,301 | I |
| 08 Jan 2025 18:09 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 08 Jan 2025 | Sale | 75,007 | 0.68 | 51,005 | I |
| 26 Dec 2024 16:34 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 20 Dec 2024 | Sale | 230,321 | 0.6 | 138,193 | I |
| 11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 09 Dec 2024 | Sale | 54,181 | 0.84 | 45,512 | I |
| 11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 10 Dec 2024 | Sale | 8,015 | 0.8 | 6,412 | I |
| 11 Dec 2024 17:32 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 11 Dec 2024 | Sale | 80 | 0.8 | 64 | I |
| 06 Dec 2024 19:07 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 04 Dec 2024 | Sale | 76,200 | 0.79 | 60,198 | I |
| 06 Dec 2024 19:07 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 06 Dec 2024 | Sale | 20,903 | 0.82 | 17,140 | I |
| 17 Oct 2024 16:17 | UPB | Upstream Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Oct 2024 | Purchase | 165,000 | 17 | 2,805,000 | I |
| 17 Oct 2024 16:17 | UPB | Upstream Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Oct 2024 | Purchase | 660,000 | 17 | 11,220,000 | I |
| 23 Sep 2024 16:51 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 19 Sep 2024 | Sale | 39,300 | 0.71 | 27,903 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 18 Sep 2024 | Sale | 25,631 | 0.73 | 18,711 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 17 Sep 2024 | Sale | 111,400 | 0.73 | 81,322 | I |
| 18 Sep 2024 18:38 | PASG | Passage BIO Inc | ORBIMED ADVISORS LLC | 10% | 16 Sep 2024 | Sale | 63,100 | 0.74 | 46,694 | I |
| 17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 250,000 | 16 | 4,000,000 | I |
| 17 Sep 2024 20:13 | MBX | MBX Biosciences Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Sep 2024 | Purchase | 500,000 | 16 | 8,000,000 | I |
| 28 Aug 2024 16:26 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 26 Aug 2024 | Sale | 83,695 | 13 | 1,088,035 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 23 Aug 2024 | Sale | 69,500 | 13.03 | 905,585 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 22 Aug 2024 | Sale | 391,482 | 12.94 | 5,065,777 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 13,300 | 14.61 | 194,313 | I |
| 23 Aug 2024 18:38 | SPRY | ARS Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director | 21 Aug 2024 | Sale | 394,400 | 13.52 | 5,332,288 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
| 15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 21,658 | 4 | 86,632 | I |
| 15 Aug 2024 16:51 | SCPH | scPharmaceuticals Inc | ORBIMED ADVISORS LLC | 10% | 13 Aug 2024 | Purchase | 478,342 | 4 | 1,913,368 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 623 | 10 | 6,230 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 556 | 10 | 5,560 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 Jul 2024 | Sale | 4,009 | 10 | 40,090 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 6,142 | 10 | 61,420 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 5,401 | 10 | 54,010 | I |
| 17 Jul 2024 20:48 | TERN | Terns Pharmaceuticals Inc | ORBIMED ADVISORS LLC | Director , 10% | 15 Jul 2024 | Sale | 39,433 | 10 | 394,330 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 02 Jul 2024 | Sale | 36,600 | 4.54 | 166,164 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 01 Jul 2024 | Sale | 13,700 | 4.68 | 64,116 | I |
| 02 Jul 2024 16:54 | TELA | TELA Bio Inc | ORBIMED ADVISORS LLC | 10% | 28 Jun 2024 | Sale | 378,000 | 4.74 | 1,791,720 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 10,986 | 36 | 395,496 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 43,944 | 36 | 1,581,984 | I |
| 20 Jun 2024 17:19 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 17 Jun 2024 | Purchase | 28,404 | 36 | 1,022,544 | I |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 1,000,000 | 22.14 | 22,140,000 | I |
| 20 May 2024 17:00 | ELVN | Enliven Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 16 May 2024 | Sale | 33,300 | 22.14 | 737,262 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 03 May 2024 | Sale | 4,674 | 14.03 | 65,576 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 02 May 2024 | Sale | 8,842 | 14.01 | 123,876 | I |
| 03 May 2024 17:16 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 01 May 2024 | Sale | 15,690 | 14.02 | 219,974 | I |
| 26 Apr 2024 17:01 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 24 Apr 2024 | Sale | 1,781 | 14.06 | 25,041 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 23 Apr 2024 | Sale | 21,791 | 14.29 | 311,393 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 22 Apr 2024 | Sale | 24,609 | 14.05 | 345,756 | I |
| 23 Apr 2024 18:38 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 19 Apr 2024 | Sale | 18,253 | 14.02 | 255,907 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 18 Apr 2024 | Sale | 2,623 | 14.06 | 36,879 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 17 Apr 2024 | Sale | 300 | 14.15 | 4,245 | I |
| 18 Apr 2024 17:10 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 16 Apr 2024 | Sale | 14,069 | 14.01 | 197,107 | I |
| 15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 11 Apr 2024 | Sale | 461,899 | 14.49 | 6,692,917 | I |
| 15 Apr 2024 17:25 | NPCE | NeuroPace Inc | ORBIMED ADVISORS LLC | 10% | 12 Apr 2024 | Sale | 23,101 | 14.42 | 333,116 | I |
| 31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
| 31 Jan 2024 16:12 | AVBP | ArriVent Biopharma Inc | ORBIMED ADVISORS LLC | Director , 10% | 30 Jan 2024 | Purchase | 222,222 | 18 | 3,999,996 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,041,700 | 2.4 | 2,500,080 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 242,200 | 2.4 | 581,280 | I |
| 26 Jan 2024 19:14 | ACET | Adicet Bio Inc | ORBIMED ADVISORS LLC | Director , 10% | 25 Jan 2024 | Purchase | 1,841,100 | 2.4 | 4,418,640 | I |
| 25 Jan 2024 16:28 | EWTX | Edgewise Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 23 Jan 2024 | Purchase | 454,545 | 11 | 4,999,995 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 139,166 | 18.32 | 2,549,521 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 1,195,683 | 18.32 | 21,904,913 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 3,128 | 19.82 | 61,997 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 28 Dec 2023 | Sale | 26,872 | 19.82 | 532,603 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 18,922 | 19.96 | 377,683 | I |
| 29 Dec 2023 16:18 | ALPN | ALPINE IMMUNE SCIENCES Inc | ORBIMED ADVISORS LLC | Director | 27 Dec 2023 | Sale | 162,576 | 19.96 | 3,245,017 | I |
| 20 Dec 2023 18:28 | IRON | Disc Medicine Inc | ORBIMED ADVISORS LLC | Director | 18 Dec 2023 | Sale | 1,724 | 59.24 | 102,130 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)